This article is for informational and educational purposes only and does not constitute medical advice. Consult your physician before starting any supplement, particularly if you have a cardiovascular condition or take prescription medications. UTCardiothoracicSurgery.com Editorial Team | January 2026. This article may contain affiliate links. If you purchase through a link in this article, a commission may be earned at no additional cost to you. This does not affect the objectivity of the information presented. FTC disclosure required by 16 C.F.R. Part 255.
Cardiac Safety Summary: CrazyBulk Stena 9009
- Product Type: Dietary supplement — proprietary anabolic formulation
- Key Ingredients: Acetyl-L-Carnitine, DMAE, Wild Yam Root extract, Choline Bitartrate (specific doses not independently verified on current label)
- Price Range: Approximately $60–$99 per bottle (30-day supply); bulk discounts reported but not verified
- Refund Policy: Reportedly 60-day money-back guarantee; terms and conditions not independently verified
- Cardiac Drug Interactions: Potential concerns with beta-blockers, stimulant-containing cardiac medications, and diuretics; incomplete ingredient transparency limits full risk assessment
- Quick Answer: CrazyBulk Stena 9009 is marketed as a performance and muscle-building supplement with limited published clinical validation. For cardiac patients, the lack of transparent ingredient dosing and potential sympathomimetic activity raise unresolved safety questions that warrant cardiologist review before use.
What Makes This Review Different: The Cardiac Safety Gap in Performance Supplements
Performance and muscle-building supplements dominate consumer markets, yet mainstream reviews rarely address the cardiovascular implications of their use in patients with existing heart conditions or taking cardiac medications. This review evaluates CrazyBulk Stena 9009 through the lens that matters most to cardiac patients: drug interaction risk, sympathomimetic activity, electrolyte effects, and blood pressure impact. General supplement reviews focus on claimed results and ingredient novelty. This analysis asks the question cardiac patients must ask: Does this formula interact with my blood pressure medication, beta-blocker, or diuretic? Does it raise heart rate or strain cardiac output? Standard reviews do not systematically address these mechanisms. This review does, because cardiac safety is not negotiable.
What CrazyBulk Stena 9009 Is: Verified Product Summary
CrazyBulk Stena 9009 is a proprietary dietary supplement marketed by CrazyBulk Ltd., a supplement manufacturer based in the United Kingdom. According to available product marketing, the formula is designed to support lean muscle development, strength gains, and fat loss through a blend of purported anabolic compounds. The product is typically supplied in capsule form, with a standard serving size of 3 capsules daily, taken before meals. The manufacturer recommends use as part of a workout regimen combined with structured resistance training and adequate protein intake. No prescription is required; it is sold as a dietary supplement under the Dietary Supplement Health and Education Act (DSHEA) framework in the United States. According to available information, the product does not contain anabolic steroids or controlled substances, though the exact manufacturing location and third-party quality testing status are not independently verified in this review.
The Label vs. Marketing Analysis: Transparency Gaps and Proprietary Blend Concerns
A critical issue emerges when comparing CrazyBulk Stena 9009 marketing claims to verifiable label data. Marketing materials emphasize dramatic muscle gain, fat loss, and performance enhancement using language often associated with pharmaceutical efficacy (“legal steroid alternative,” “anabolic results without needles”). However, the actual Supplement Facts panel—according to available information—does not disclose individual ingredient doses, relying instead on a proprietary blend format. This is a significant transparency red flag for cardiac patients. When specific doses are hidden, clinicians cannot assess interaction potential with cardiac medications or calculate cumulative stimulant exposure. For example, if the formula contains caffeine, tyramine-containing ingredients, or compounds with sympathomimetic properties at high doses, undisclosed amounts prevent a cardiologist from evaluating safety for a patient on a beta-blocker or ACE inhibitor. The marketing also emphasizes “legal” and “safe” positioning, yet provides no independent clinical safety data, published efficacy trials, or cardiac contraindication statements. This discrepancy between marketing boldness and label conservatism is typical of the supplement category but carries greater risk for patients with cardiovascular disease.
CrazyBulk Stena 9009 Ingredients: Evidence and Cardiac Dosing Concerns
According to available product information, CrazyBulk Stena 9009 reportedly contains Acetyl-L-Carnitine (ALCAR), DMAE (dimethylaminoethanol), Wild Yam Root extract, and Choline Bitartrate as primary active components. However, because the formula uses a proprietary blend, individual doses remain undisclosed—a limitation that directly impairs cardiac safety assessment.
Acetyl-L-Carnitine (ALCAR): Research suggests ALCAR may support mitochondrial energy production and, in some studies, shows modest effects on exercise performance. Clinical trials typically use 1–3 grams daily. The cardiac concern is modest but real: ALCAR can be converted to trimethylamine by gut bacteria, which the liver converts to TMAO (trimethylamine-N-oxide), a metabolite associated with increased cardiovascular risk in some observational studies. For patients with heart failure or atherosclerosis, long-term ALCAR accumulation warrants discussion with a cardiologist, particularly at undisclosed doses in a proprietary blend.
DMAE (Dimethylaminoethanol): Marketed as a cognitive and mood enhancer, DMAE has mild sympathomimetic properties—meaning it may subtly elevate heart rate and blood pressure in some users. Published evidence is limited and mixed. For cardiac patients on beta-blockers or diuretics, even mild sympathomimetic activity can undermine medication efficacy or trigger unwanted tachycardia. The lack of disclosed dose makes individual risk assessment impossible.
Wild Yam Root Extract: Marketed for hormone support, wild yam contains diosgenin, a phytoestrogen precursor. Evidence that it meaningfully affects testosterone or hormonal balance in humans is weak. Cardiac concern: phytoestrogens may interact with blood pressure and fluid balance in susceptible individuals. Clinical doses and long-term safety in cardiac populations remain understudied.
Choline Bitartrate: A precursor to acetylcholine, choline supports cell membrane function. Typical supplemental doses range from 500–2,000 mg daily. Like ALCAR, excessive choline can produce TMAO through gut bacterial metabolism, raising the same cardiovascular risk signal in high-risk populations. Again, undisclosed dose prevents precise risk assessment.
Overall, no individual ingredient at typical clinical doses poses an obvious acute cardiac hazard. However, the cumulative effect of multiple ingredients with sympathomimetic or TMAO-raising potential, combined with complete absence of dose transparency, creates a pattern of unquantified risk that cardiac patients cannot responsibly assess without explicit physician review of the full ingredient list with amounts.
CrazyBulk Stena 9009 Cardiac Safety Profile: Drug Interactions and Specific Warnings
This is the critical section for any cardiac patient considering CrazyBulk Stena 9009. The following drug interaction categories apply:
Beta-Blockers (e.g., metoprolol, atenolol, carvedilol): If CrazyBulk Stena 9009 contains undisclosed sympathomimetic components (DMAE, stimulants, or stimulant precursors), even mild beta-adrenergic stimulation could antagonize beta-blocker efficacy, potentially raising heart rate and blood pressure despite medication. For patients post-myocardial infarction or with heart failure, this undermines critical cardioprotection.
ACE Inhibitors and Angiotensin II Receptor Blockers (ACEi/ARBs): No direct contraindication is evident; however, sympathomimetic activity combined with ACE inhibition can create unpredictable blood pressure effects. Monitoring is advisable.
Diuretics (furosemide, hydrochlorothiazide, spironolactone): ALCAR and Choline both carry TMAO-raising potential. In heart failure patients already at cardiovascular risk from diuretic-induced electrolyte shifts, additional TMAO elevation may add incremental risk. Additionally, any sympathomimetic activity can reduce diuretic efficacy.
Statins (atorvastatin, simvastatin, rosuvastatin): No direct interaction is documented; however, ALCAR supplementation in statin users warrants hepatic function monitoring, as both may modestly affect liver metabolism.
Anticoagulants and Antiplatelet Agents (warfarin, apixaban, aspirin, clopidogrel): No reported direct interaction; however, supplements marketed with anabolic intent sometimes include undisclosed herbal ingredients with anticoagulant or platelet-modifying properties. The proprietary blend format prevents exclusion of this risk.
Nitrates and Phosphodiesterase-5 Inhibitors: If sympathomimetic activity is present, combined use could trigger unpredictable blood pressure swings—a serious concern for patients with angina or erectile dysfunction medications.
Bottom Line for Cardiac Patients: The combination of sympathomimetic potential, TMAO-raising ingredient candidates, and complete lack of dose transparency creates a risk profile that cannot be safely cleared without full ingredient disclosure and explicit cardiologist approval. Patients should not assume “legal supplement” equals “cardiac-safe supplement.”
CrazyBulk Stena 9009 User-Reported Outcomes: Evidence Limitations
According to available information, CrazyBulk Stena 9009 has garnered user reviews on third-party sites and the manufacturer's website, with reported outcomes ranging from modest muscle gain and improved strength to minimal or no effect. However, this review found no published randomized controlled trials, peer-reviewed efficacy data, or independent clinical validation for the product. User reviews are inherently biased (satisfied customers are more likely to leave positive reviews), unverified for actual product use, and do not assess safety in cardiac populations. The volume and independence of reviews could not be verified. For cardiac patients, the absence of published safety or efficacy data is a material gap—relying on anecdotal user reports for a product with undisclosed dosing is high-risk decision-making.
CrazyBulk Stena 9009 Pricing and Refund Terms
CrazyBulk Stena 9009 is reportedly priced between $60–$99 USD per bottle, with each bottle containing a 30-day supply at the recommended 3-capsule-daily dose. The manufacturer markets bulk purchase discounts (e.g., “buy two, get one free”) to reduce per-unit cost. According to available product information, a 60-day money-back refund guarantee is offered; however, the specific terms—including whether return shipping is required, when the 60-day window begins (order date vs. receipt date), and the contact process—are not independently verified. Readers should verify these terms directly with the manufacturer before purchase. Pricing is subject to change. Verify current pricing on the manufacturer's official listing.
Buyer Takeaway: Evidence-Based Verdict for Cardiac Patients
CrazyBulk Stena 9009 is a performance supplement with no published clinical efficacy data, no demonstrated cardiac safety profile, and a critical transparency gap: the use of a proprietary blend that hides individual ingredient doses. For healthy individuals, this may represent an acceptable trade-off between cost and unproven efficacy. For cardiac patients, it does not. Here is what the evidence supports and what it does not:
What the evidence does not support: That CrazyBulk Stena 9009 produces meaningful, lasting muscle gain or fat loss beyond what structured training and diet achieve. No RCT has been published in peer-reviewed journals.
What the evidence does support: That individual ingredients (ALCAR, DMAE, choline) have known biological activity and documented interaction mechanisms with cardiac medications. That proprietary blends obscure risk assessment. That sympathomimetic and TMAO-raising potential exists.
Cardiac Recommendation: Patients with a history of heart attack, heart failure, arrhythmia, hypertension requiring medication, or those taking beta-blockers, ACE inhibitors, diuretics, or anticoagulants should not use this product without explicit written approval from their cardiologist. The risk-benefit calculation is unfavorable: uncertain benefit paired with quantifiable but unquantified risk. A safer alternative for cardiac patients seeking to build lean muscle is supervised resistance training, cardiology-approved nutrition, and—if supplementation is desired—single-ingredient supplements with transparent labeling and published cardiac safety data.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for educational purposes only and does not constitute medical advice. Results vary by individual. Consult your physician before starting any supplement, particularly if you take cardiovascular or metabolic medications.
Related Reading on UT Cardiothoracic Surgery
- PDE5 Inhibitors and Blood Pressure Medications: Drug Interactions Every Man on Cardiac Meds Should Understand
- Erectile Dysfunction and Heart Disease: Why ED May Be an Early Warning Sign of Cardiovascular Problems
- Compounded ED Combinations and Heart Medications: Nitrates, Blood Pressure, and Cardiac Safety
- Peak State Male Performance: Cardiac Safety Review 2026